Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Nelson

Showing results (251-260 of 442) with videos related to

Pageof 45
Sort By:
Journal of Clinical Gastroenterology|September 12, 2009
A meta-analysis of transient elastography for the detection of hepatic fibrosisJustin Stebbing, Lavanta Farouk, George Panos, et al.
The Journal of Infection|December 15, 2011
Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIVGurmit K Jagjit Singh, Samreen Ijaz, Neesha Rockwood, et al.
Experimental and Molecular Pathology|January 1, 2021
Effects of 9-t-butyl doxycycline on the innate immune response to CNS ischemia-reperfusion injuryNguyen Mai, Sara A Knowlden, Kathleen Miller-Rhodes, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 19, 2005
Periodic arrays of interfacial cylindrical reverse micellesMark Nelson, Nicholas Cain, Chad E Taylor, et al.
International Journal of Cancer|December 30, 2003
The efficacy of ritonavir in the prevention of AIDS-related Kaposi's sarcomaJustin Stebbing, Simon Portsmouth, Mark Nelson, et al.
AIDS (London, England)|April 20, 2004
Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals?Alan Winston, Anton Pozniak, Nicola Smith, et al.
BMJ Open|July 28, 2020
Self-directed multimedia process for delivering participant informed consentNiamh Chapman, Rebekah McWhirter, Matthew K Armstrong, et al.
AIDS Research and Human Retroviruses|August 17, 2006
Pharmacokinetics of saquinavir hard-gel/ritonavir and atazanavir when combined once daily in HIV Type 1-infected individuals administered different atazanavir dosesMarta Boffito, Desmond Maitland, Laura Dickinson, et al.
Vaccine|December 3, 2014
Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infectionAnna Herasimtschuk, Jocelyn Downey, Mark Nelson, et al.
Comprehensive Psychoneuroendocrinology|September 27, 2023
The association between adverse events in later life and mortality in older individualsDinuli Nilaweera, Caroline Gurvich, Rosanne Freak-Poli, et al.
Pageof 45

Showing results (251-260 of 442) with videos related to

Sort By:
Pageof 45
Journal of Clinical Gastroenterology|September 12, 2009
A meta-analysis of transient elastography for the detection of hepatic fibrosisJustin Stebbing, Lavanta Farouk, George Panos, et al.
The Journal of Infection|December 15, 2011
Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIVGurmit K Jagjit Singh, Samreen Ijaz, Neesha Rockwood, et al.
Experimental and Molecular Pathology|January 1, 2021
Effects of 9-t-butyl doxycycline on the innate immune response to CNS ischemia-reperfusion injuryNguyen Mai, Sara A Knowlden, Kathleen Miller-Rhodes, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 19, 2005
Periodic arrays of interfacial cylindrical reverse micellesMark Nelson, Nicholas Cain, Chad E Taylor, et al.
International Journal of Cancer|December 30, 2003
The efficacy of ritonavir in the prevention of AIDS-related Kaposi's sarcomaJustin Stebbing, Simon Portsmouth, Mark Nelson, et al.
AIDS (London, England)|April 20, 2004
Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals?Alan Winston, Anton Pozniak, Nicola Smith, et al.
BMJ Open|July 28, 2020
Self-directed multimedia process for delivering participant informed consentNiamh Chapman, Rebekah McWhirter, Matthew K Armstrong, et al.
AIDS Research and Human Retroviruses|August 17, 2006
Pharmacokinetics of saquinavir hard-gel/ritonavir and atazanavir when combined once daily in HIV Type 1-infected individuals administered different atazanavir dosesMarta Boffito, Desmond Maitland, Laura Dickinson, et al.
Vaccine|December 3, 2014
Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infectionAnna Herasimtschuk, Jocelyn Downey, Mark Nelson, et al.
Comprehensive Psychoneuroendocrinology|September 27, 2023
The association between adverse events in later life and mortality in older individualsDinuli Nilaweera, Caroline Gurvich, Rosanne Freak-Poli, et al.
Pageof 45